Diarrhea

• 

  Subject Areas on Research

  • A childlike presentation? 
  • A phase II study of docetaxel-irinotecan combination in advanced pancreatic cancer. 
  • A pressing situation. 
  • A randomized controlled trial of household-based flocculant-disinfectant drinking water treatment for diarrhea prevention in rural Guatemala. 
  • A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer. 
  • A slow disengagement from platinum-based chemotherapy for patients with advanced non-small cell lung cancer. 
  • A two-year study of bacterial, viral, and parasitic agents associated with diarrhea in rural Bangladesh. 
  • A very low-carbohydrate diet improves symptoms and quality of life in diarrhea-predominant irritable bowel syndrome. 
  • AIDS-associated diarrhea and wasting in Northeast Brazil is associated with subtherapeutic plasma levels of antiretroviral medications and with both bovine and human subtypes of Cryptosporidium parvum. 
  • Acrodermatitis enteropathica-like eruption and food allergy. 
  • Acute infectious diarrhea. 
  • Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer. 
  • An outbreak of Escherichia coli O157 infection following exposure to a contaminated building. 
  • Antimicrobial-Resistant Shigella spp. in San Diego, California, USA, 2017-2020. 
  • Antimotility agents for the treatment of acute noninfectious diarrhea in critically ill patients: A practice management guideline from the Eastern Association for the Surgery of Trauma. 
  • Application of rejection criteria for stool ovum and parasite examinations. 
  • Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. 
  • Assessment of Long-Term Bowel Symptoms After Segmental Resection of Deeply Infiltrating Endometriosis: A Matched Cohort Study. 
  • Associated symptoms in the ten days before diagnosis of Kawasaki disease. 
  • Bacterial indicators of risk of diarrhoeal disease from drinking-water in the Philippines. 
  • Bacteriotherapy for clostridium difficile colitis. 
  • Basic fibroblast growth factor among children with diarrhea-associated hemolytic uremic syndrome. 
  • Bevacizumab, oxaliplatin, and capecitabine with radiation therapy in rectal cancer: Phase I trial results. 
  • Blurred Lines: Dysbiosis and Probiotics in the ICU. 
  • Body temperature is a poor predictor of malaria parasitaemia in children with acute diarrhoea. 
  • Bowel function, sexual function, and symptoms of pelvic organ prolapse in women with and without urinary incontinence. 
  • Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial. 
  • Campylobacter enteritis. 
  • Campylobacter enteritis: clinical and epidemiologic features. 
  • Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study. 
  • Case report: chylous ascites and carcinoid tumors: possible association of two rare disorders. 
  • Cases from the Osler Medical Service at Johns Hopkins University. 
  • Characteristics of primary care and rates of pediatric hospitalizations in Brazil. 
  • Chronic rotavirus infection in an infant with severe combined immunodeficiency: successful treatment by hematopoietic stem cell transplantation. 
  • Clinical and immunologic significance of cholera-like toxin and cytotoxin production by Campylobacter species in patients with acute inflammatory diarrhea in the USA. 
  • Clinical outcomes of patients with advanced gastrointestinal stromal tumors: safety and efficacy in a worldwide treatment-use trial of sunitinib. 
  • Clinical practice. Acute infectious diarrhea. 
  • Clostridium difficile cure with fecal microbiota transplantation in a child with Pompe disease: a case report. 
  • Clostridium difficile infection among kidney transplant recipients: frequency, clinical presentation, and outcome. 
  • Clostridium difficile infection in obstetric and gynecologic patients. 
  • Comparative effects of vivax malaria, fever, and diarrhea on child growth 
  • Comparing serologic response against enteric pathogens with reported diarrhea to assess the impact of improved household drinking water quality. 
  • Control of diarrhoeal diseases. 
  • Criterion-related validity of a diarrhea questionnaire in HIV-infected patients. 
  • Cryptosporidium species, a protean protozoan. 
  • Cryptosporidium, enterocytozoon, and cyclospora infections in pediatric and adult patients with diarrhea in Tanzania. 
  • Desensitization to pancreatic enzyme intolerance in a child with cystic fibrosis. 
  • Detailing of gastrointestinal symptoms in cancer patients with advanced disease: new methodologies, new insights, and a proposed approach. 
  • Detection of Escherichia coli enterotoxins in stools. 
  • Developing a scorecard to assess global progress in scaling up diarrhea control tools: a qualitative study of academic leaders and implementers. 
  • Diarrhea in a Patient With Combined Kidney-Pancreas Transplant. 
  • Diarrhea, demography and cell signaling: lessons from microbial toxins. 
  • Diarrhea. 
  • Diarrhea: applying research to bedside practice. 
  • Diarrheal Illness and Healthcare Seeking Behavior among a Population at High Risk for Diarrhea in Dhaka, Bangladesh. 
  • Diarrhoea associated with heat-stable enterotoxin-producing strains of Escherichia coli. 
  • Diarrhoeal disease control: reviews of potential interventions. 
  • Diarrhoeal disease in Bangladesh: epidemiology, mortality averted and costs at a rural treatment centre. 
  • Differential Diagnosis of Diarrhea in Patients With Neuroendocrine Tumors. 
  • Direct observation of hygiene in a Peruvian shantytown: not enough handwashing and too little water. 
  • Disease due to enterotoxigenic Escherichia coli in Bangladeshi adults: clinical aspects and a controlled trial of tetracycline. 
  • Disease surveillance methods used in the 8-site MAL-ED cohort study. 
  • Donepezil for the treatment of language deficits in adults with Down syndrome: a preliminary 24-week open trial. 
  • Donepezil for treatment of cognitive dysfunction in children with Down syndrome aged 10-17. 
  • Doxycycline and the traveller. 
  • Drivers of the reduction in childhood diarrhea mortality 1980-2015 and interventions to eliminate preventable diarrhea deaths by 2030. 
  • Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study. 
  • Editorial: Toxigenic turista. 
  • Effect Of A Large-Scale Social Franchising And Telemedicine Program On Childhood Diarrhea And Pneumonia Outcomes In India. 
  • Effect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: results of the Comparative HDL Efficacy and Safety Study (CHESS). 
  • Effects of Shigella-, Campylobacter- and ETEC-associated diarrhea on childhood growth. 
  • Efficacy and safety of fidaxomicin compared with oral vancomycin for the treatment of adults with Clostridium difficile-associated diarrhea: data from the OPT-80-003 and OPT-80-004 studies. 
  • Efficacy and toxicity of doxorubicin/cyclophosphamide maintenance therapy in dogs with multicentric lymphosarcoma. 
  • Enriched brucella medium for storage and transport of cultures of Campylobacter fetus subsp. jejuni. 
  • Enteric viruses associated with HIV infection in Tanzanian children with chronic diarrhea. 
  • Enteroinvasive Escherichia coli: a cause of bacteremia in patients with AIDS. 
  • Enterotoxigenic Escherichia coli and Reovirus-like agent in rural Bangladesh. 
  • Epidemiologic assessment of the relevance of the so-called enteropathogenic serogroups of Escherichia coli in diarrhea. 
  • Epidemiology and Impact of Campylobacter Infection in Children in 8 Low-Resource Settings: Results From the MAL-ED Study. 
  • Escherichia coli serotypes and diarrhea. 
  • Evaluating associations between vaccine response and malnutrition, gut function, and enteric infections in the MAL-ED cohort study: methods and challenges. 
  • Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19). 
  • Evaluation of a social franchising and telemedicine programme and the care provided for childhood diarrhoea and pneumonia, Bihar, India 
  • Evolution of the World Health Organization's programmatic actions to control diarrheal diseases. 
  • Examining the Nocebo Effect in Trials of Neuromodulators for Use in Disorders of Gut-Brain Interaction. 
  • Factors associated with the decline in under-five diarrhea mortality in India: a LiST analysis. 
  • Failure to thrive, diarrhea, cough, and oral candidiasis in a three-month-old boy. 
  • Fecal steroids in diarrhea. II. Travellers' diarrhea. 
  • Fidaxomicin for treatment of clostridium difficile-associated diarrhea and its potential role for prophylaxis. 
  • Fluorescent-antibody test for detection of Clostridium difficile in stool specimens. 
  • From Rwanda to Wisconsin: the global relevance of diarrhoeal diseases. 
  • Full breastfeeding protection against common enteric bacteria and viruses: results from the MAL-ED cohort study. 
  • Functional bowel and anorectal disorders in patients with pelvic organ prolapse and incontinence. 
  • Gastrointestinal Microbiome Disruption and Antibiotic-Associated Diarrhea in Children Receiving Antibiotic Therapy for Community-Acquired Pneumonia. 
  • Gastrointestinal illness on passenger cruise ships. 
  • Global progress in the control of diarrheal diseases. 
  • Glucose and lipid effects of the ileal apical sodium-dependent bile acid transporter inhibitor GSK2330672: double-blind randomized trials with type 2 diabetes subjects taking metformin. 
  • Glucose vs sucrose in oral rehydration solutions for infants and young children with rotavirus-associated diarrhea. 
  • Glutamine therapy improves outcome of in vitro and in vivo experimental colitis models. 
  • Gut microbial succession follows acute secretory diarrhea in humans. 
  • Healthcare associated diarrhea, not Clostridioides difficile. 
  • High prevalence of malaria parasitemia and anemia among hospitalized children in Rakai, Uganda. 
  • High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. City of Hope Bone Marrow Oncology Team. 
  • High-dose, single-agent irinotecan as first-line therapy in the treatment of metastatic colorectal cancer. 
  • Hospitalization for community-acquired, rotavirus-associated diarrhea: a prospective, longitudinal, population-based study during the seasonal outbreak. The Greater Toronto Area/Peel Region PRESI Study Group. Pediatric Rotavirus Epidemiology Study for Immunization. 
  • Household based treatment of drinking water with flocculant-disinfectant for preventing diarrhoea in areas with turbid source water in rural western Kenya: cluster randomised controlled trial. 
  • Hyper IgM Syndrome: a Report from the USIDNET Registry. 
  • Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial. 
  • Immune checkpoint inhibitor gastritis is often associated with concomitant enterocolitis, which impacts the clinical course. 
  • Inappropriate Clostridium difficile Testing and Consequent Overtreatment and Inaccurate Publicly Reported Metrics. 
  • Infectious diarrhea in developed and developing countries. 
  • Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials. 
  • Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis. 
  • Interaction between acute diarrhoea and falciparum malaria in Nigerian children. 
  • Intestinal parasites and HIV infection in Tanzanian children with chronic diarrhea. 
  • LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept. 
  • Laboratory investigation of diarrhea in travelers to Mexico: evaluation of methods for detecting enterotoxigenic Echerichia coli. 
  • Lack of association between falciparum malaria parasitemia and acute diarrhea in Nigerian children. 
  • Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31. 
  • Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial. 
  • Management of irritable bowel syndrome. 
  • Managing toxicities of phosphatidylinositol-3-kinase (PI3K) inhibitors. 
  • Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000-17. 
  • Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000-17: analysis for the Global Burden of Disease Study 2017. 
  • Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000-17. 
  • Methods of analysis of enteropathogen infection in the MAL-ED Cohort Study. 
  • Mid-trimester abortion induced by intravaginal administration of prostaglandin E2 suppositories. 
  • Midtrimester abortion induced by serial intramuscular injections of 15(S)-15-methyl-prostaglandin F2alpha. 
  • Midtrimester abortion induced by single intra-amniotic instillation of two dose schedules of 15(S)-15-methyl-prostaglandin F2alpha. 
  • Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trial. 
  • Modeling environmental influences on child growth in the MAL-ED cohort study: opportunities and challenges. 
  • Molecular epidemiology of Rotavirus causing diarrhea among children less than five years of age visiting national level children hospitals, Nepal. 
  • Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016. 
  • Mortality rates in conflict zones in Karen, Karenni, and Mon states in eastern Burma. 
  • Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. 
  • Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial. 
  • Multiple endocrine neoplasia type 1 manifesting with chronic and persistent diarrhea. 
  • Multiple relapses of Clostridium difficile-associated diarrhea in a cancer patient. Successful control with long-term cholestyramine therapy. 
  • Multiseptate gallbladder. 
  • Nonfebrile illness seizures: a unique seizure category? 
  • Norovirus Infection and Acquired Immunity in 8 Countries: Results From the MAL-ED Study. 
  • Novel pathogenic variants in FOXP3 in fetuses with echogenic bowel and skin desquamation identified by ultrasound. 
  • Nutritional status, body size and severity of diarrhoea associated with rotavirus or enterotoxigenic Escherichia coli. 
  • Obesity in pediatric celiac disease. 
  • Of Taps and Toilets: Quasi-experimental protocols for evaluating community-demand driven projects 
  • Oral rehydration therapy for treatment of rotavirus diarrhoea in a rural treatment centre in Bangladesh. 
  • Part III. Analysis of data gaps pertaining to enterotoxigenic Escherichia coli infections in low and medium human development index countries, 1984-2005. 
  • Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). 
  • Pathogenic Escherichia coli in children with and without chronic diarrhea in Tanzania. 
  • Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival. 
  • Peptide YY: a gut hormone associated with anorexia during infectious diarrhea in children. 
  • Persistent diarrhea in the returned traveler. 
  • Persistent diarrhoea in Nigerian children aged less than five years: a hospital-based study. 
  • Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas. 
  • Phase 1 trial of ibrutinib and carfilzomib combination therapy for relapsed or relapsed and refractory multiple myeloma. 
  • Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma. 
  • Phase I clinical and plasma and cellular pharmacological study of topotecan without and with granulocyte colony-stimulating factor. 
  • Phase I study of 5-day continuous infusion fluorodeoxyuridine and high-dose folinic acid with oral hydroxyurea. 
  • Phase I trial of pazopanib in patients with advanced cancer. 
  • Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901. 
  • Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma. 
  • Phase II study of docetaxel in advanced soft tissue sarcomas. 
  • Phase II trial of 5-fluorouracil plus eniluracil in patients with advanced pancreatic cancer: a Southwest Oncology Group study. 
  • Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma. 
  • Plakoglobin and High-Mobility Group Box 1 Mediate Intestinal Epithelial Cell Apoptosis Induced by Clostridioides difficile TcdB. 
  • Postdural puncture headache with abdominal pain and diarrhea. 
  • Practice guidelines for the management of infectious diarrhea. 
  • Prevalence and significance of inflammatory bowel disease-like morphologic features in collagenous and lymphocytic colitis. 
  • Prevention of traveler's diarrhea. 
  • Pseudomembranous colitis presenting as mild, chronic diarrhea in childhood. 
  • Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. 
  • Public health impacts of ecosystem change in the Brazilian Amazon 
  • Rapid enteric testing to permit targeted antimicrobial therapy, with and without Lactobacillus reuteri probiotics, for paediatric acute diarrhoeal disease in Botswana: A pilot, randomized, factorial, controlled trial. 
  • Recommended patient-reported core set of symptoms and quality-of-life domains to measure in ovarian cancer treatment trials. 
  • Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. 
  • Refeeding during recovery from acute diarrhea. 
  • Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. 
  • Restoring the Microbiome in Critically Ill Patients: Are Probiotics Our True Friends When We Are Seriously Ill? 
  • Rotavirus-associated diarrhea in outpatient settings and child care centers. The Greater Toronto Area/Peel Region PRESI Study Group. Pediatric Rotavirus Epidemiology Study for Immunization. 
  • Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer: a phase 1b study. 
  • Scaling up oral rehydration salts and zinc for the treatment of diarrhoea. 
  • Sequential clinical and histopathological changes in collagenous and lymphocytic colitis over time. 
  • Severity of Clostridium difficile-associated diarrhea in solid organ transplant patients. 
  • Socioecological correlates of clinical signs in two communities of wild chimpanzees (Pan troglodytes) at Gombe National Park, Tanzania. 
  • Solid-phase microtiter radioimmunoassay blocking test for detection of antibodies to Escherichia coli heat-labile enterotoxin. 
  • Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease. 
  • Species identification and virulence attributes of Saccharomyces boulardii (nom. inval.). 
  • Suppository administration of chemotherapeutic drugs with concomitant radiation for rectal cancer. 
  • Symptom and function profiles of men with localized prostate cancer. 
  • Symptom outcomes important to women with anal incontinence: a conceptual framework. 
  • Tackling Infectious Diarrhea in Hematopoietic Cell Transplantation. 
  • The Diagnostic Yield of Site and Symptom-Based Biopsies for Acute Gastrointestinal Graft-Versus-Host Disease: A 5-Year Retrospective Review. 
  • The HIV-positive traveler. 
  • The MAL-ED study: a multinational and multidisciplinary approach to understand the relationship between enteric pathogens, malnutrition, gut physiology, physical growth, cognitive development, and immune responses in infants and children up to 2 years of age in resource-poor environments. 
  • The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings. 
  • The effect of a 10 cm2, 0.5% 15-ME-PGF2alpha methyl ester intravaginal silastic device on abortion and plasma prostaglandin concentration. 
  • The impact of rotavirus gastroenteritis on the family. 
  • The know-do gap in quality of health care for childhood diarrhea and pneumonia in rural India. 
  • The magnitude of the global problem of acute diarrhoeal disease: a review of active surveillance data. 
  • The use of somatostatin and its analogs in the treatment of surgical disorders. 
  • Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia. 
  • Toxigenic Vibrio cholerae serogroup O141-associated cholera-like diarrhea and bloodstream infection in the United States. 
  • Transcutaneous electric nerve stimulation over acupoints for patients with diarrhea-predominant irritable bowel syndrome: Protocol for systematic review and meta-analysis. 
  • Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial. 
  • Travelers with sickle cell disease. 
  • Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress. 
  • Travelers' diarrhea. 
  • Treatment of thrombosed hemorrhoids by excision. 
  • Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study. 
  • Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study. 
  • Uncovering the Harms of Treating Clostridioides difficile Colonization. 
  • Upstream watershed condition predicts rural children's health across 35 developing countries. 
  • Urgency and fecal soiling in people with bowel dysfunction. 
  • Use of colony pools for diagnosis of enterotoxigenic Escherichia coli diarrhea. 
  • Use of quantitative molecular diagnostic methods to assess the aetiology, burden, and clinical characteristics of diarrhoea in children in low-resource settings: a reanalysis of the MAL-ED cohort study. 
  • Use of quantitative molecular diagnostic methods to investigate the effect of enteropathogen infections on linear growth in children in low-resource settings: longitudinal analysis of results from the MAL-ED cohort study. 
  • Vietnam during economic transition: a tracer study of health service access and affordability. 
  • Village-based distribution of oral rehydration therapy packets in Bangladesh. 
  • Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms? 
  • [A case of congenital malabsorption of lactose]. 
  • [Clinical study of Daritran]. 
  • [Confronting diarrhea on a worldwide scale]. 
  • [Oral rehydration in acute intestinal diseases]. 
  • [The WHO program for controlling diarrheic diseases: its status and developmental outlook--the organizational and operative components of the program]. 
  • rHuKGF ameliorates symptoms in DSS and CD4(+)CD45RB(Hi) T cell transfer mouse models of inflammatory bowel disease. 
• 

  Keywords of People

  • Yancy Jr., William Samuel, Professor of Medicine, Medicine, General Internal Medicine
  • Yoo, Sua, Associate Professor of Radiation Oncology, Radiation Oncology